Home > Insider Trading > Filing (0000899243-18-028970)

Filing Details

Accession Number:: 0000899243-18-028970
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-14 21:03:55
Reporting Period:: 2018-11-09

Accepted Time:: 2018-11-14 21:03:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896262	Amedisys Inc	AMED	Services-Home Health Care Services (8082)	113131700

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1694097	Christopher Gerard	3854 American Way, Suite A Baton Rouge LA 70816	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-11-09	7,892	$46.35	29,429	No	4	M	Direct
Common Stock	Disposition	2018-11-09	5,600	$118.64	23,829	No	4	S	Direct
Common Stock	Disposition	2018-11-09	2,292	$119.94	21,537	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-11-09	7,892	$0.00	7,892	$46.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
23,675		2027-01-20	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	211	Indirect	Through 401(k) Plan

Footnotes

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.30 to $119.09, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.52 to $120.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The information in this report is based on a plan statement dated as of September 30, 2018.
On January 20, 2017, the reporting person was granted an option to purchase 31,567 shares of common stock. The option vested as to 7,892 shares on January 20, 2018, and the remaining 23,675 options vest in equal installments on each of January 20, 2019, January 20, 2020 and January 20, 2021, provided that the reporting person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the stock option.